Avanos Medical Inc (AVNS)

Financial leverage ratio

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Total assets	US$ in thousands	1,692,400	1,724,900	1,666,700	1,734,900	1,786,900	1,775,200	1,752,800	1,766,500	1,603,600	1,597,900	1,683,300	1,648,800	1,672,800	1,799,100	1,755,900	1,763,700	1,799,600	1,807,700	1,783,400	1,834,000
Total stockholders’ equity	US$ in thousands	1,236,300	1,222,100	1,234,800	1,298,700	1,291,200	1,263,500	1,259,000	1,262,800	1,270,600	1,267,100	1,301,700	1,257,400	1,262,100	1,289,900	1,261,600	1,256,500	1,272,600	1,266,900	1,276,900	1,280,100
Financial leverage ratio		1.37	1.41	1.35	1.34	1.38	1.40	1.39	1.40	1.26	1.26	1.29	1.31	1.33	1.39	1.39	1.40	1.41	1.43	1.40	1.43

December 31, 2023 calculation

Financial leverage ratio = Total assets ÷ Total stockholders’ equity
= $1,692,400K ÷ $1,236,300K
= 1.37

The financial leverage ratio of Avanos Medical Inc has shown some variations over the past eight quarters. The ratio has ranged from a low of 1.34 in Q1 2023 to a high of 1.41 in Q3 2023 and Q1 2022. This indicates that the company's reliance on debt to finance its operations and investments has fluctuated slightly during this period.

Overall, the average financial leverage ratio for Avanos Medical Inc over the past eight quarters is approximately 1.39, suggesting that, on average, the company has maintained a moderate level of financial leverage in its capital structure. It is important for stakeholders to monitor fluctuations in this ratio as changes in financial leverage can impact the company's risk profile and cost of capital.